期刊文献+

循证医学在代谢综合征生命网干预中的临床研究 被引量:3

The Evidence-based Medicine Study of Metabolic Syndrome and Intervene Study with Heartcare Network
下载PDF
导出
摘要 目的:应用循证医学方法将生命网模式应用于代谢综合征高危人群,为制定相应的干预措施提供依据。方法:将196例患者分为干预组和对照组,干预组运用生命网干预,观察血糖、血压、糖化血红蛋白等危险因素的转归。结果:入网1、3、6月、1年随访,各组分危险因素经干预治疗后,具有统计学意义。结论:通过循证医学研究,生命网干预可为高危人群提供一套综合治疗、定期随访、健康教育及干预为一体的系统服务,是有效控制肥胖、高血糖、血脂紊乱、高血压等危险组分的治疗模式。 Objective: Apply evidence - based medicine to metabolic syndrome for new treatment. Method: 196 patients were random divided into intervene group and control group. Intervene group were given heartcare network intervene. Plasma glucose ,blood pressure,HbA1 c were examined. Result: Afterl, 3,6,12months intervene treatment, the various risk factors in metabolic syndrome were were decreased after treatment intervene. Conclusion: Heartcare network intervene were important ways to control obesity, hyper- glycemia , hyperlipidemia and hypertension.
出处 《河北医学》 CAS 2007年第4期436-439,共4页 Hebei Medicine
关键词 循证医学 代谢综合征 生命网 Evidence -based medicine Metabolic syndrome (MS) Heartcare network
  • 相关文献

参考文献4

二级参考文献9

  • 1Vaccro O, Ruth KJ, Stamler J. Relationship of postload plasma glucose to mortality with 19-yr follow-up: comparison of one versus two plasma measurements in the Chicago Peoples Gas Company Study, Diabetes Care 1992 ;15 :1328 -1334.
  • 2Menotti A, Keys A, Blackburn H, et al. Comparison of coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year folow-up. J Cardiovasc Risk 1996; 3:69 - 75.
  • 3Hall JE, Brands MV, Dixon WN, et al. Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension 1993 ;36 : 355 - 365.
  • 4Fried SK, Ricci MR, Russell CD, et al. Regulation of leptin productionin humans. J Nutr 2000;130:3127-3131.
  • 5Isomaa B, A lmgren P, Tuom i T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes Care 2001 ;24(4) :683 - 689.
  • 6Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002 ;288:2709 - 2716.
  • 7Lebovitz HE. Insulin resistance: definition and consequences.Exp Clin Endocrinol Diabetes 2001,109(2) :S1352 - 1481.
  • 8Breuer HW. Hypertriglyceridemia: areview of clinical relevance and treatment options: focus on cerivastatin. Curr Med Res Opin 2001;17(1):60-73.
  • 9刘芳,张红叶,刘晓宁,杨浣宜,康朝辉,史秀忠,杨瑛,惠汝太.代谢综合征与动脉粥样硬化的关系[J].中华医学杂志,2003,83(15):1317-1320. 被引量:44

共引文献11

同被引文献13

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部